RxDoctor Payments Data

Gregory Darnell, MD

Family Medicine · Dunbar, WVNPI 1811492499

Payments from drug & device makers

$1,474in general payments, 2019–2025

Across 100 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$607
  • Novo Nordisk$460
  • Lilly USA, LLC$100
  • Abbott$60
  • Novartis$57
  • Dexcom, Inc.$27
  • plus $163 from 10 others

What the payments were for

  • Food & beverage$1,474100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,474 in reported general payments places this provider in the 75th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$66,231
Medicare patients
287
Services billed
662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$95,681
EliquisApixaban82$83,185
OzempicSemaglutide38$51,752
JanuviaSitagliptin Phosphate44$47,024
FarxigaDapagliflozin Propanediol21$32,905
XareltoRivaroxaban26$25,486
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,771
MounjaroTirzepatide11$10,990
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen381$7,151
GemtesaVibegron12$5,681
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$5,267
Gabapentin166$2,950
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$2,689
Atorvastatin Calcium311$2,508
Levothyroxine Sodium233$2,422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$83,18582 claims
Novo NordiskOzempic$460$51,75238 claims
AstraZenecaFarxiga$16$32,90521 claims
GSKTrelegy Ellipta$14$18,77119 claims
Lilly USA, LLCMounjaro$100$10,99011 claims
AbbVieSynthroid$607$1,72724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Dunbar

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →